Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis

Antiresorptive agents are widely used to treat osteoporosis. Both reduction in bone turnover and increase in BMD may be necessary to decrease the fracture risk. The aim of the study was to evaluate the effects of aledronate on bone turnover markers and bone mineral density in postmenopausal women wi...

Full description

Bibliographic Details
Main Authors: Elma Kučukalić-Selimović, Amina Valjevac, Almira Hadžović-Džuvo, Amra Skopljak-Beganović, Rubina Alimanovic-Alagić, Amera Brković
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2011-02-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
postmenopausal osteoporosis
bone turnover markers
bone mineral density
alendronate
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/2622

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/2622

Similar Items